These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8302574)
1. Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Carlesso N; Griffin JD; Druker BJ Oncogene; 1994 Jan; 9(1):149-56. PubMed ID: 8302574 [TBL] [Abstract][Full Text] [Related]
2. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Okuda K; Golub TR; Gilliland DG; Griffin JD Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524 [TBL] [Abstract][Full Text] [Related]
5. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223 [TBL] [Abstract][Full Text] [Related]
6. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells. Danhauser-Riedl S; Warmuth M; Druker BJ; Emmerich B; Hallek M Cancer Res; 1996 Aug; 56(15):3589-96. PubMed ID: 8758931 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148). Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840 [TBL] [Abstract][Full Text] [Related]
8. Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line. Laneuville P; Heisterkamp N; Groffen J Oncogene; 1991 Feb; 6(2):275-82. PubMed ID: 1705688 [TBL] [Abstract][Full Text] [Related]
9. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Evans CA; Owen-Lynch PJ; Whetton AD; Dive C Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase. Ren SY; Xue F; Feng J; Skorski T Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545 [TBL] [Abstract][Full Text] [Related]
11. bcr/abl expression in 32D cl3(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors. Laneuville P; Timm M; Hudson AT Cancer Res; 1994 Mar; 54(5):1360-6. PubMed ID: 8118826 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover. Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551 [TBL] [Abstract][Full Text] [Related]
13. C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis. Skorski T; Nieborowska-Skorska M; Szczylik C; Kanakaraj P; Perrotti D; Zon G; Gewirtz A; Perussia B; Calabretta B Cancer Res; 1995 Jun; 55(11):2275-8. PubMed ID: 7757976 [TBL] [Abstract][Full Text] [Related]
14. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL. Salgia R; Brunkhorst B; Pisick E; Li JL; Lo SH; Chen LB; Griffin JD Oncogene; 1995 Sep; 11(6):1149-55. PubMed ID: 7566975 [TBL] [Abstract][Full Text] [Related]
15. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544 [TBL] [Abstract][Full Text] [Related]
16. p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia. Pierce A; Owen-Lynch PJ; Spooncer E; Dexter TM; Whetton AD Oncogene; 1998 Aug; 17(5):667-72. PubMed ID: 9704934 [TBL] [Abstract][Full Text] [Related]
17. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase. Brusa G; Benvenuti M; Mazzacurati L; Mancini M; Pattacini L; Martinelli G; Barbieri E; Greenberger JS; Baccarani M; Santucci MA Haematologica; 2003 Jun; 88(6):622-30. PubMed ID: 12801837 [TBL] [Abstract][Full Text] [Related]
18. Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. Underhill-Day N; Pierce A; Thompson SE; Xenaki D; Whetton AD; Owen-Lynch PJ Br J Haematol; 2006 Mar; 132(6):774-83. PubMed ID: 16487179 [TBL] [Abstract][Full Text] [Related]
19. Establishment, characterization, and chromosomal analysis of new leukemic cell lines derived from MT/p210bcr/abl transgenic mice. Honda H; Ohno S; Takahashi T; Takatoku M; Yazaki Y; Hirai H Exp Hematol; 1998 Mar; 26(3):188-97. PubMed ID: 9502614 [TBL] [Abstract][Full Text] [Related]